The prefrontal cortex is the brain region responsible for what scientists call executive functions: working memory, attention, decision-making, and the ability to plan and adapt. These are precisely the mental skills an athlete needs when reading a game, anticipating an opponent’s next move, or adjusting tactics mid-competition. Because the prefrontal cortex sits directly beneath the skull at the front of the head, it is uniquely accessible to functional near-infrared spectroscopy, or fNIRS, the optical method the researchers employed. fNIRS works by shining near-infrared light through the scalp and skull and measuring how much of it is absorbed or scattered by the blood flowing underneath. Because oxygenated hemoglobin and deoxygenated hemoglobin absorb light at slightly different wavelengths, the technique can distinguish between the two and track changes in local brain oxygenation with fine temporal resolution, all while a person is awake, moving, or performing a cognitive task.

The study team recruited twelve trained male athletes and divided them into two groups based on body mass index. The low-BMI group had an average BMI of 24.68 plus or minus 2.54 kilograms per square meter, while the high-BMI group averaged 33.91 plus or minus 5.73 kilograms per square meter, a level that falls into the obese range on standard clinical classifications. Each participant completed a familiarization session first, followed by an experimental session in which body mass and hematocrit, the proportion of blood volume occupied by red blood cells, were measured both before and after exercise. Hematocrit served as a physiological marker of dehydration: as plasma volume shrinks with fluid loss, the relative concentration of red blood cells rises, so a post-exercise increase in hematocrit indicates that hypohydration has occurred.

The exercise protocol itself was deliberately standardized so that any differences between the groups could be attributed to their physiological responses rather than to different workloads. Participants cycled at a constant load of 100 watts at a cadence of 60 revolutions per minute for 30 minutes, followed by four 20-second sprint intervals designed to push them closer to their physiological limits. This combination of steady submaximal work and short, intense bursts mirrors the demands of many real-world sports, from soccer and basketball to cycling races, where sustained effort is punctuated by moments of all-out exertion. Throughout the session, the researchers monitored how much body mass each athlete lost, providing a direct estimate of sweat-driven fluid loss.

The cognitive centerpiece of the experiment was the 2-back task, a widely used test of working memory. In this task, participants view a sequence of stimuli and must indicate whenever the current item matches the one presented two steps earlier. Holding that running comparison in mind requires sustained engagement of the prefrontal cortex, which is why the task is a favorite among cognitive neuroscientists studying executive function. The researchers recorded prefrontal hemodynamic activity with fNIRS while the athletes performed the 2-back task, both before and after the exercise protocol, allowing them to compare how the same brain region responded to the same mental challenge in two very different hydration states.

The physiological results confirmed that the exercise protocol successfully induced hypohydration in both groups. Hematocrit levels rose significantly after exercise compared with pre-exercise baseline values in both the high-BMI and low-BMI groups, but the increase was significantly greater in the high-BMI athletes, with a reported p-value of 0.045. This suggests that, under identical exercise conditions, the athletes with higher BMI experienced a more pronounced shift in blood composition, consistent with greater fluid loss or a larger reduction in plasma volume. Because blood volume and cardiovascular stability are tightly linked to cerebral blood flow, this difference set the stage for the brain-level findings that followed.

Those brain-level findings were striking precisely because the two groups diverged in opposite directions. In the low-BMI group, prefrontal oxyhemoglobin increased during the post-exercise 2-back test compared with pre-exercise performance, a statistically robust change with a p-value of 0.002. Rising oxyhemoglobin during a cognitive task is generally interpreted as a sign of increased neural recruitment: the brain is calling in more oxygenated blood to support the working-memory demands of the task. In the high-BMI group, by contrast, the researchers observed an increase in deoxyhemoglobin, with a p-value of 0.033, and an increase in total hemoglobin that just reached the conventional significance threshold at p equal to 0.050. Rising deoxyhemoglobin alongside increased total hemoglobin can indicate that oxygen extraction from the blood is outpacing oxygen delivery, a pattern that may reflect a less efficient hemodynamic response or a mismatch between neural demand and vascular supply under the combined stress of dehydration and cognitive load.

The behavioral data added a further layer of concern for the high-BMI athletes. When the researchers tallied the number of missing answers on the post-exercise 2-back test, the high-BMI group produced significantly more omissions than the low-BMI group. Missing answers on a working-memory task can reflect lapses in attention, reduced task engagement, or genuine degradation in working-memory capacity, and the authors of the study interpret this pattern as evidence of reduced task engagement or diminished working-memory performance in the dehydrated high-BMI athletes. Taken together with the divergent hemodynamic signatures, the picture that emerges is one in which higher body mass index appears to alter both the brain’s vascular response to dehydration and the cognitive performance that depends on it.

It is important to emphasize, as the researchers themselves do, that these are preliminary findings and must be interpreted with caution. The sample size was small, with only twelve participants divided across two groups, and the study lacked a euhydrated control condition, meaning there was no group that performed the same exercise and cognitive testing while maintaining normal hydration. Without that control, it is difficult to fully separate the effects of dehydration itself from the effects of exercise, fatigue, or individual variability. The authors explicitly state that their conclusions should be confirmed in larger, controlled studies before firm recommendations can be drawn. Nevertheless, the study’s design was rigorous for a preliminary investigation: it was reviewed and approved by the Dokuz Eylul University Non-Invasive Research Ethics Committee, conducted in accordance with the Helsinki Declaration, and all adult participants provided written informed consent before taking part.

If the findings hold up in larger trials, the implications could be significant for sports science and athletic practice. Hydration strategies are already a cornerstone of elite performance planning, but they are typically designed around physical metrics such as core temperature, heart rate, and sweat rate. This study raises the possibility that cognitive protection, preserving the prefrontal cortex’s ability to support decision-making and working memory under physiological stress, should be an explicit goal of hydration protocols, and that individualized targets may be needed for athletes with higher body mass index. The work also highlights the value of fNIRS as a portable, exercise-compatible window into the working brain, allowing researchers to study cognition in contexts that traditional imaging methods such as MRI cannot easily reach. As the authors and the broader field continue to explore how body composition, hydration status, and cerebral hemodynamics interact, this preliminary study offers a compelling early signal that the brain’s response to dehydration is not one-size-fits-all, and that the athletes who most need sharp thinking in the final minutes of competition may be the ones whose brains are most vulnerable to the fluid they have lost.

Subject of Research: Effects of body mass index on prefrontal cortex hemodynamics and working memory during exercise-induced hypohydration in male athletes

Article Title: The effect of body mass index on prefrontal cortex hemodynamic and cognitive functions in exercise-induced hypohydration in male athletes: preliminary study

Article References: Bediz, C., Uylas, E., Guducu, C., Manci, E., & Gunay, E. (2026). The effect of body mass index on prefrontal cortex hemodynamic and cognitive functions in exercise-induced hypohydration in male athletes: preliminary study. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01062-x

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01062-x

Keywords: exercise-induced hypohydration, prefrontal cortex, body mass index, fNIRS, working memory, 2-back task, hemodynamics, athletes, dehydration, cognitive performance, sports physiology, BMC Neuroscience

Sensory gating is one of the nervous system’s most economical tricks. When two identical stimuli arrive in quick succession, the brain’s response to the second is normally dampened relative to the first, a phenomenon measured by the ratio of the second response to the first. This suppression is not fixed; it depends heavily on the interstimulus interval, the gap between the two pulses. At very short intervals the cortical circuitry is still recovering and the second response is strongly attenuated, while at longer intervals the response gradually rebounds. The pattern reflects the recovery dynamics of thalamocortical synapses and local inhibitory circuits, and it allows the cortex to emphasize novel input while suppressing redundant input. In clinical settings, disturbances of sensory gating have been linked to a range of conditions, from migraine to schizophrenia, making the mechanism a sensitive readout of brain health.

To test how sustained pain reshapes this system, the team applied paired-pulse electrical stimulation to the median nerve of anesthetized rats, delivering two pulses separated by interstimulus intervals of 35, 50, 80, 140, and 500 milliseconds. Evoked potentials were recorded directly from the primary somatosensory cortex, the cortical region that receives and processes touch and proprioceptive information from the body. The researchers then injected capsaicin, the pungent compound in chili peppers that activates TRPV1 receptors on nociceptive C-fibers, into the territory served by the nerve. Capsaicin produces a well-characterized model of sustained peripheral nociceptive input: it does not destroy the nerve, but it drives a prolonged barrage of pain-related signals from the periphery into the central nervous system. Recordings were repeated at 60 and 120 minutes after the injection, allowing the team to track how the cortical response evolved as the pain signal persisted.

The results were striking in their asymmetry. Compared with vehicle-treated controls, capsaicin significantly increased the amplitude and the area under the curve of the first response, S1, while simultaneously decreasing the S2/S1 amplitude ratio across the entire two-hour recording window. In other words, the cortex responded more vigorously to the initial stimulus, but the relative suppression of the second stimulus deepened. At first glance that combination may seem paradoxical, but the authors interpret it as a change in response gain: the whole input-output function of the cortical circuit was scaled up, so the first response grew while the recovery-dependent second response failed to keep pace. Crucially, this effect appeared to be independent of the interstimulus interval. In the normal brain, the degree of gating varies systematically with the gap between pulses; after capsaicin, that orderly interval-dependent structure was largely lost, replaced by a flattened, interval-insensitive profile.

The study went beyond conventional evoked potentials by examining high-frequency oscillations, or HFOs, the fast rhythmic components superimposed on somatosensory evoked responses. These oscillations are thought to arise from distinct neuronal generators, with early components reflecting activity in inhibitory interneuron networks and later components tied to thalamocortical relay activity. When the researchers decomposed the evoked responses into frequency bands, they found that both the early and late components of the S1 response were significantly increased in the 50 to 150 Hz domain after capsaicin. Even more notably, the early component of the area under the S1 response increased prominently in the 400 to 800 Hz band, an extremely fast range that is rarely accessible in routine human recordings but can be resolved with direct cortical electrodes in animal models.

These frequency-specific changes carry physiological weight. The 50 to 150 Hz range overlaps with gamma-band activity, which is associated with local cortical processing and has been implicated in pain-related cortical dynamics in both animal and human studies. The 400 to 800 Hz bursts, sometimes called very high-frequency oscillations, are believed to index the firing of populations of inhibitory interneurons in the superficial layers of the cortex. A disproportionate amplification of the early, very high-frequency component of S1 suggests that sustained nociceptive input acts at the earliest stages of cortical sensory processing, altering the excitability of the local inhibitory network before the signal is even relayed through the canonical cortical columns. The authors propose that capsaicin-induced nociceptive drive modified the response gain of the cortex while simultaneously abolishing the normal interval-dependent recovery function, a dual insult that degrades the brain’s ability to temporally parse incoming sensory information.

Why does this matter for understanding chronic pain? Temporal discrimination, the ability to distinguish two stimuli that arrive close together in time, depends on precisely the gating mechanism the study measured. Patients with neuropathic pain and other chronic pain conditions frequently report allodynia, hyperalgesia, and difficulty separating simultaneous sensations, symptoms that could plausibly arise from a cortex whose gain has been turned up and whose interval-dependent filter has been disabled. The current findings provide an electrophysiological substrate for those clinical observations: sustained peripheral nociceptive input does not merely add a painful signal on top of normal processing, it reorganizes the processing itself. The disproportionate effect on S1, the initial cortical response, points to early sensory processing as a key site of pain-related plasticity, rather than the higher-order associative regions that have traditionally attracted most attention.

The methodology deserves attention as well. By sampling five interstimulus intervals spanning more than a fourteenfold range, from 35 to 500 milliseconds, and by recording at two time points after the nociceptive challenge, the experiment captured both the temporal structure and the time course of the gating disruption. The finding that capsaicin’s effects did not vary meaningfully with interval values was itself an important negative result: the authors state that they could not clearly detect a significant contribution of ISI values to capsaicin’s effects on sensory processing regulation. That absence of interval dependence is precisely what one would expect if sustained nociceptive input had overwritten the recovery dynamics of the thalamocortical circuit, replacing a tuned filter with a uniformly amplified, uniformly suppressed regime.

There are, of course, limits to what an anesthetized rat model can tell us about human pain perception. Capsaicin injection is an acute model of sustained nociception rather than a true chronic pain state, and cortical responses recorded under anesthesia may differ in important ways from those in a behaving, conscious animal. The authors also note that the study was conducted without external funding, and the work was approved by the Gazi University Local Ethics Committee for Animal Experiments. Nevertheless, the model has strong translational precedent, and the electrophysiological markers identified here, particularly the S2/S1 ratio and the high-frequency oscillation profile, have direct analogues in human somatosensory evoked potential recordings, raising the possibility of biomarkers for pain-related cortical dysfunction.

The broader lesson is that pain is not just a sensation; it is a modulator of sensation. By driving a sustained stream of nociceptive traffic into the thalamocortical system, a persistent pain source appears to hijack the gain control and temporal filtering that the cortex relies on to organize all incoming sensory information. If confirmed in further studies, this mechanism could help explain the sensory chaos that many chronic pain patients describe, and it suggests that therapies aimed at restoring normal cortical gating, rather than simply blocking pain signals at their source, might offer a route to relieving the full burden of the condition. For now, the rat cortex has delivered a clear message: when pain will not stop talking, the brain stops listening properly to everything else.

Subject of Research: Effects of sustained peripheral nociceptive input on sensory gating in the rat primary somatosensory cortex

Article Title: Sustained peripheral nociceptive input disrupts interstimulus-interval-dependent sensory gating in the rat primary somatosensory cortex

Article References: Tepe, N., Boran, H. E., Geduk, S., Dileköz, E., Sara, Y., & Bolay, H. (2026). Sustained peripheral nociceptive input disrupts interstimulus-interval-dependent sensory gating in the rat primary somatosensory cortex. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01053-y

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01053-y

Keywords: sensory gating, chronic pain, capsaicin, somatosensory cortex, high-frequency oscillations, interstimulus interval, nociception, thalamocortical pathway, evoked potentials, neurophysiology, TRPV1, BMC Neuroscience

The core problem with conventional peripheral nerve stimulation lies in its lack of selectivity. When a cuff electrode wrapped around a nerve delivers current, it activates many types of fibers at once: the large, heavily myelinated Aα and Aβ fibers that carry touch and proprioceptive signals toward the spinal cord, the thinner Aδ fibers associated with sharp pain, and the efferent motor fibers that drive muscles. For pain relief, clinicians generally want to activate only the large sensory Aα/Aβ fibers, which can suppress pain transmission through gating mechanisms in the spinal cord. But because electrical stimulation cannot reliably distinguish afferent sensory fibers from efferent motor fibers, the current must be capped at levels that avoid unwanted muscle contractions. That ceiling can leave the therapeutic target population under-activated, blunting the treatment’s analgesic effect.

Optogenetics has long been proposed as an elegant solution. By introducing light-sensitive proteins such as channelrhodopsin 2 (ChR2) into specific populations of neurons, researchers can activate precisely those cells with pulses of light while leaving neighboring fibers untouched. In the new study, the team used transgenic mice expressing ChR2 and recorded compound action potentials (CAPs), the summed electrical signature of many axons firing together, from the sciatic nerve of anaesthetized animals. The results confirmed the selectivity promise: optogenetic stimulation activated Aα/Aβ fibers with impressive precision and produced no motor response at all, something electrical stimulation cannot achieve. For a field struggling to silence pain without triggering twitching limbs or tingling side effects, that selectivity is a major prize.

But there was a catch, and it is a serious one. When the researchers delivered tonic optogenetic stimulation, continuous trains of light pulses lasting up to 60 seconds at clinically relevant frequencies ranging from 4 to 100 Hz, the nerve responses faded dramatically. The optically evoked compound action potentials, or oCAPs, declined in an exponential and strongly frequency-dependent manner, with the statistical analysis showing a highly significant frequency effect (p < 0.001). At stimulation rates above 20 Hz, the response often vanished entirely, leaving no detectable signal even while the light continued to flash. In other words, the very thing that makes optogenetics selective also makes it fragile: the light-activated channels and the fibers themselves fatigue quickly, and the technique as it currently stands is simply untenable for the sustained stimulation that real-world pain therapy demands, even at low frequencies.

Electrical stimulation did not escape unscathed either. The electrically evoked compound action potentials, or eCAPs, also declined over the course of the 60-second stimulation trains, and they did so in a frequency-dependent, dual-phase exponential pattern that the team captured statistically (p < 0.001). This biphasic decay suggests two overlapping processes: a rapid initial drop, likely reflecting activity-dependent changes in axonal excitability such as hyperpolarization or potassium accumulation, followed by a slower secondary decline. Clinicians and device engineers have long observed that nerve responses wane during continuous stimulation, and this study quantifies that phenomenon precisely in the large sensory fiber population that pain therapy seeks to recruit, across the exact frequency range used in clinical peripheral nerve stimulation devices.

The most striking findings emerged when the researchers combined the two modalities. Delivering light and electrical stimulation together produced what the team describes as a facilitated response: the combined electrically and optically evoked CAP, or cCAP, was larger than what either stimulus could achieve alone. Across the entire stimulation period, more than 85 percent of the recorded responses showed this facilitation, and critically, the effect was maintained regardless of stimulation frequency (p = 0.33). The rapid initial reduction in response amplitude for combined stimulation was actually greater than that seen with electrical stimulation alone (p < 0.05), but after that fast phase, the response settled into a similar secondary decline as the electrical-only condition (p = 0.10). The net result, however, was a response that stayed larger and more sustained than either modality could deliver on its own.

Why does combining light and electricity boost the response? The mechanistic picture that emerges from this and earlier work is that the two stimuli act on the fibers through partially independent pathways. Electrical stimulation directly depolarizes the axonal membrane at the electrode, while optogenetic stimulation opens light-gated channels distributed along the ChR2-expressing sensory neurons. When both are applied, the depolarizations summate, preferentially boosting activation in the genetically targeted population of large sensory fibers. Because the electrical component does not fatigue in the same way as the optical one, it appears to prop up the response during the periods when the optically driven component would otherwise collapse. The consequence is a stimulus that retains the selectivity of the optogenetic approach, targeting only the Aα/Aβ fibers, while achieving the sustained responsiveness that pure light-based stimulation lacks.

The clinical implications are considerable. Peripheral nerve stimulation devices are already implanted in patients for chronic pain, but their efficacy is limited by the current ceilings imposed by motor fiber activation and by the inherent non-selectivity of electrical currents. If a hybrid device could deliver a small, safe electrical pulse alongside targeted optical activation of ChR2-expressing sensory fibers, it might achieve stronger and more sustained recruitment of the therapeutic fiber population without crossing into motor territory. The Melbourne team’s demonstration that facilitated responses persist across the full 4 to 100 Hz clinical frequency range, and throughout stimulation trains lasting a full minute, provides exactly the kind of preclinical evidence needed to justify pushing this approach toward translational development. This study adds to growing evidence that combined stimulation could improve the analgesic effect of existing peripheral nerve stimulation methods.

Significant hurdles remain before any such device reaches patients. Optogenetics in humans requires gene delivery, typically via adeno-associated viruses, to introduce light-sensitive proteins into the target neurons, and translating the transgenic mouse approach used here into a safe and durable human therapy is a formidable challenge involving dosing, immune responses and long-term expression. Light delivery to deep peripheral nerves also requires implanted LEDs or optical fibers, adding engineering complexity. The study itself was conducted in isoflurane-anaesthetized mice over relatively short stimulation windows, so questions about responses over hours, days or weeks of continuous use remain open. Ethical oversight was rigorous: all procedures were approved by the St Vincent’s Hospital Animal Ethics Committee in Melbourne and conducted under Australian animal welfare guidelines.

Nevertheless, the study represents a methodical and important step forward. By systematically comparing electrical, optogenetic and combined stimulation across clinically relevant frequencies and durations, and by quantifying the decay dynamics of each with rigorous statistical modeling, Ardren, Wrobel, Matarazzo, Thompson, Fallon, Richardson and their colleagues have given the neuromodulation field a clear-eyed assessment of what each approach can and cannot do. Optogenetics alone, however selective, cannot yet sustain the signals needed for therapy. Electrical stimulation alone, however durable, cannot select its targets. Together, the data suggest, they cover each other’s weaknesses. For the millions of chronic pain patients whose conditions resist every existing treatment, that combination, light and current working in concert, may be the most promising avenue yet for making nerve stimulation devices finally live up to their promise. The research was funded by the National Health and Medical Research Council and the Bionics Institute Incubation Fund, with support from the Victorian Government, and is published open access so that researchers worldwide can build on its findings immediately.

Subject of Research: How optogenetic, electrical and combined stimulation recruit large sensory nerve fibers in the mouse sciatic nerve during sustained neuromodulation for chronic pain treatment.

Article Title: Recruitment of Aα/Aβ fibers during tonic electrical, optogenetic and combined stimulation in the mouse sciatic nerve

Article References: Ardren, M. G., Wrobel, B., Matarazzo, J. V., Thompson, A. C., Fallon, J. B., & Richardson, R. T. (2026). Recruitment of Aα/Aβ fibers during tonic electrical, optogenetic and combined stimulation in the mouse sciatic nerve. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01049-8

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01049-8

Keywords: optogenetics, peripheral nerve stimulation, chronic pain, neuromodulation, sciatic nerve, A-alpha/A-beta fibers, compound action potential, channelrhodopsin, electrical stimulation, neuroengineering, BMC Neuroscience, pain therapy

The study was motivated by a gap in the existing literature. Most research on digital media and cognition has focused on total screen time, treating hours of use as the key exposure variable. The authors argue that this approach misses the structure of modern digital behaviour. Generation Z university students, often described as digital natives, do not simply use their phones a lot; they use them in a particular pattern, dominated by brief sessions, frequent pickups and a substantial share of passive consumption such as scrolling through content without active engagement. To capture that structure, the researchers set out to characterize the entire digital footprint, including duration, fragmentation and content type, and to test how each dimension relates to cognitive control.

The methodology combined ecological realism with statistical rigour. Participants were health sciences students whose smartphones recorded seven days of objective usage logs. Rather than bringing students into a laboratory to perform a computerized task on unfamiliar equipment, the team deployed a custom mobile Stroop task that participants completed on their own devices, maximizing ecological validity. In the Stroop paradigm, people must name the ink colour of a word while ignoring the word itself; incongruent trials, where the word and colour conflict, tax the brain’s conflict-resolution machinery, while congruent trials, where word and colour match, can be resolved largely by automatic processing. A clinical battery also assessed sleep quality, attention deficit hyperactivity disorder symptoms, anxiety, headache, neck disability and computer vision syndrome, allowing the researchers to separate digital habits from somatic and psychiatric burden.

The objective data painted a portrait of intensive, highly fragmented use. The median participant logged 6.6 hours of daily screen time, picked up the phone 142 times per day, and averaged just 2.9 minutes per session, with roughly 40 percent of consumption being passive. These numbers quantify what many people intuitively recognize: the modern smartphone day is not a few long engagements but a continuous drip of micro-sessions, each one an interruption of whatever came before. The researchers also developed a Cumulative Digital Load Score, a self-report measure intended to summarize this burden, and compared it against the device logs.

Analyses proceeded on two levels. First, theory-driven family-based correlation analyses, corrected for multiple comparisons across 13 tests using the false discovery rate procedure, examined how screen patterns related to Stroop performance. These analyses showed that fragmentation metrics were significantly associated with conflict resolution costs, meaning that students whose phone use was most broken up performed worse when faced with incongruent, conflicting information. Second, trial-level linear mixed-effects models were fitted across 12,035 individual Stroop trials, allowing the researchers to isolate the momentary effects of different predictors on accuracy trial by trial, rather than relying on coarse summary scores.

The results of the modelling revealed two distinct profiles of impairment. High digital attention fragmentation was linked to a selective weakening of proactive cognitive control: it increased errors specifically on incongruent trials, the trials that require maintaining an intention and applying it against interference. In contrast, clinical and somatic symptom burden, along with ADHD symptomatology, was associated with a broader accuracy cost that extended even to highly automated congruent trials. Particularly for somatic pain burdens, the deficit was not confined to effortful conflict resolution but spilled over into tasks that normally run on autopilot. This dissociation is analytically important, because it suggests that fragmented media use and clinical symptom load degrade cognition through different mechanisms rather than a single generic impairment.

Passive consumption told its own story. The study found that passive use was associated with block-dependent processing delays, slowing responses without affecting performance on highly automatic cognitive tasks. The authors are careful to flag a limitation here: because the two task blocks were administered in a fixed order, this contrast is confounded with task order and practice effects, so the passive consumption finding should be interpreted with caution. Even so, the pattern fits a model in which passive scrolling dulls momentary processing speed while leaving automated routines intact, whereas fragmentation erodes the more strategic, anticipatory layer of executive control.

One of the study’s most sobering results concerns measurement itself. The convergence between the self-reported Cumulative Digital Load Score and the objective device logs was weak, with correlations of roughly 0.14 to 0.18. In other words, what students believed about their digital load and what their phones actually recorded captured related but distinct aspects of behaviour, not interchangeable estimates of the same construct. This has practical implications far beyond the study: much of the existing literature on screen time and mental health rests on self-report, and this work adds to growing evidence that subjective estimates of device use can diverge substantially from reality.

The authors’ conclusion resists a simple moral panic. Digital exposure, they argue, does not produce a single, homogeneous cognitive deficit. Instead, the data support a more nuanced account in which the pattern of use matters more than the volume. Highly fragmented use, defined by constant interruptions and short session durations, is associated with poorer proactive cognitive control and a specific accuracy cost on demanding trials, while passive consumption is linked to processing delays that spare automatic cognition. Because the study is cross-sectional, it cannot establish causation; it remains possible that people with weaker proactive control are also more prone to fragmenting their attention, rather than fragmentation causing the deficit. Longitudinal and interventional work will be needed to settle the direction of the relationship.

Even with that caveat, the practical message is actionable. If fragmentation, not duration, is the cognitive culprit, then cognitive health in the digital age may benefit from targeted digital hygiene strategies that prioritize minimizing attention fragmentation, such as batching notifications, lengthening uninterrupted periods and reducing the sheer number of pickups, rather than fixating solely on cutting total screen time. For a generation whose phones register more than a hundred pickups a day, the difference between six and four hours of screen time may matter far less than whether those hours arrive as sustained engagement or as a storm of two-minute fragments. The study, funded in part by TÜBA and approved by the Gazi University Ethics Commission, offers a technically sophisticated template for asking that question with objective data, and it reframes the debate about screens from how much to how.

Subject of Research: How smartphone use fragmentation and passive consumption relate to cognitive control in Generation Z university students.

Article Title: The neurocognitive cost of media multitasking: fragmented screens, fragmented minds!

Article References: Ince, M. S., Guzel, I., Bahcelioglu, M., & Bolay, H. (2026). The neurocognitive cost of media multitasking: fragmented screens, fragmented minds!. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01043-0

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01043-0

Keywords: media multitasking, cognitive control, digital footprint, screen fragmentation, passive consumption, proactive control, Stroop task, digital phenotyping, smartphone use, ADHD symptoms, digital hygiene, BMC Neuroscience

The work addresses a persistent bottleneck in preclinical stroke research. The most widely used animal model of ischemic stroke, the transient middle cerebral artery occlusion (tMCAO) model, is typically assessed by staining brain sections with 2,3,5-triphenyltetrazolium chloride, or TTC. Living tissue stains a vivid red, while infarcted tissue remains pale white. For decades, researchers have measured the volume of the white region by manually tracing its boundary on images of each slice — a labor-intensive process whose accuracy depends on the training, fatigue, and judgment of the individual observer.

The new system, developed by Ziyuan Tang, Meng Li, and colleagues in the laboratories of Chang’an A. Zhan and Fengxian Li, takes a fundamentally different approach: it lets the pixel values of the image do the work. The algorithm decomposes each TTC-stained slice image into its separate RGB and HSV color channels and analyzes the histogram of pixel values in each channel. From these distributions, the software establishes thresholds that distinguish not just one damaged region but two: the ischemic core, where tissue has died outright, and the ischemic penumbra — the salvageable zone of endangered tissue surrounding the core that most existing analyses simply ignore.

The ischemic penumbra is far from a technical footnote. It is the region that neuroprotective therapies aim to rescue, and its extent shapes a patient’s prognosis. Yet in both manual tracing and conventional automated methods, the penumbra tends to be lumped together with the core or lost entirely, because the pale gradient between healthy red tissue and dead white tissue is difficult to delineate by eye or by simple thresholding. By quantifying each region separately, and weighting the score by the mean pixel value of the penumbra, the algorithm captures gradations of damage that volume measurements alone miss.

To determine which color channel carried the most reliable information, the team correlated each channel-based score with measurements made by experienced human observers. The blue channel emerged as the clear winner, showing the strongest correlation with manual assessment and the most accurate recognition of the boundary between penumbra and core. The resulting severity metric correlated with manual measurement with a Pearson coefficient of 0.9392, and with automated thresholding performed in the popular open-source Fiji software with a coefficient of 0.8885 — figures that place the algorithm comfortably in the range of agreement between trained humans themselves.

Crucially, the team did not stop at comparing pixels with tracings. They asked whether the new severity score actually reflected how sick the animals were. Mice underwent standardized neurological behavioral testing before their brains were collected 24 hours after the stroke surgery. The algorithm’s severity output correlated with the neurological deficit score at Spearman r = 0.7492, beating both manual measurement (r = 0.7206) and conventional automated measurement (r = 0.6528). In other words, the color-derived score predicted real-world motor impairment better than the methods it was designed to replace.

The researchers then tested whether the system would generalize beyond the tMCAO model, which blocks a major cerebral artery by briefly inserting a filament. In a photothrombotic stroke model — a fundamentally different technique in which a photosensitive dye and laser light trigger clotting in targeted surface vessels — the severity score again correlated significantly with manual measurement, suggesting the algorithm is not tuned to the quirks of a single experimental paradigm but captures something general about how infarcted tissue looks under TTC staining.

The implications for the field could be substantial. Preclinical stroke research has been shadowed by a reproducibility crisis, with hundreds of seemingly promising therapies failing to translate from mice to humans. Sources of measurement variability, including subjective lesion assessment, are frequently cited as contributors to that failure. An objective, high-throughput scoring method that removes observer bias, quantifies the penumbra, and correlates strongly with functional outcomes offers a way to standardize endpoints across laboratories — and potentially to detect subtler treatment effects in drug screens than manual scoring can resolve.

The system is also strikingly accessible. Unlike deep-learning approaches that require large annotated training datasets and specialized computing hardware, this algorithm relies on classical image analysis: channel decomposition, histogram analysis, and threshold-based labeling that can run on ordinary slice images. The authors describe it as a rapid, objective, and accurate tool for high-throughput evaluation of stroke outcomes in basic research, and the study was supported by the National Natural Science Foundation of China. While the work remains at the preclinical stage, it points toward a future in which the color of a stained brain section — read by software rather than by eye — becomes a common currency for comparing stroke severity across experiments, models, and laboratories.

Subject of Research: An automated image color difference algorithm for scoring cerebral infarct severity in mouse stroke models

Article Title: A mouse cerebral infarct severity scoring system based on image color difference algorithm

Article References: Tang, Z., Li, M., Wang, T., Zhang, H., Zhan, C. A., & Li, F. (2026). A mouse cerebral infarct severity scoring system based on image color difference algorithm. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01047-w

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01047-w

Keywords: ischemic stroke, cerebral infarction, TTC staining, image analysis, tMCAO model, ischemic penumbra, mouse model, neurological score, photothrombotic stroke, computer-assisted image processing, BMC Neuroscience, stroke research

The scientific question underlying the study is deceptively simple: what happens inside the fetal brain when a pregnant mother experiences chronic stress? Epidemiological work in humans has long suggested that children born to mothers who endure significant stress during pregnancy face elevated risks of cognitive difficulties, anxiety, and other neuropsychiatric conditions. Animal models have replicated these observations, but the molecular choreography connecting maternal stress hormones to lasting changes in brain function has remained only partially mapped. The new research homes in on one specific player in that choreography: the resident immune cells of the brain, called microglia, and a protein they produce known as Galectin-3, or Gal-3.

Microglia are the brain’s frontline surveillance cells, constantly scanning their environment and responding to injury or infection. When activated, they change shape, engulf debris, and release inflammatory signaling molecules called cytokines. In moderation, this response is protective and essential for healthy brain development, since microglia help prune and remodel neural circuits during critical developmental windows. But when microglial activation becomes excessive or prolonged, the resulting neuroinflammation can damage neurons and disrupt the formation of the very circuits that support learning and memory. Galectin-3 has emerged in recent years as a marker and possible driver of this harmful activation, and it has been implicated in neurodegenerative and inflammatory brain disorders, making it a compelling candidate for explaining how prenatal stress translates into adult cognitive dysfunction.

To test this idea, the research team turned to a well-established rodent model. Twelve pregnant Sprague-Dawley rats were randomly divided into two groups. From gestational day 15 to day 21, the final week before birth, six of the dams were subjected to restraint stress, a standard and ethically controlled way of inducing psychological stress in laboratory animals. The remaining six dams experienced no intervention and served as controls. Once the offspring reached adulthood, the researchers put them through a battery of behavioral assessments designed to probe different dimensions of brain function: the open-field test and elevated plus maze for anxiety-like behavior and exploratory activity, the novel object recognition test for declarative memory, and the Y-maze test for working memory and spatial navigation.

The behavioral results were unambiguous. Compared with offspring of unstressed mothers, the prenatal stress group showed significant impairments across all four tests, indicating disruptions in both emotional regulation and core cognitive domains. The team then measured the hormonal footprint of stress by using enzyme-linked immunosorbent assays to quantify corticotropin-releasing hormone and corticosterone, two central components of the hypothalamic-pituitary-adrenal axis, in the peripheral blood of both mothers and offspring. Levels of both hormones rose significantly in stressed dams, confirming that the manipulation worked, and, strikingly, they were also elevated in the adult offspring, with the strongest statistical differences appearing in the young animals whose mothers had endured the restraint protocol.

With the behavioral and hormonal phenotypes established, the researchers turned to the molecular evidence. Assays of peripheral blood serum and of tissue from two brain regions critically involved in cognition, the hippocampus and the prefrontal cortex, revealed significantly increased expression of the inflammatory cytokines interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha in the prenatally stressed offspring. These molecules are classic signatures of an immune system in overdrive. Their presence in both blood and brain tissue suggested that maternal stress had ignited inflammatory pathways that persisted long after the initial stressor had ended, effectively leaving the adult brain in a chronically inflamed state.

Immunofluorescence staining then allowed the team to visualize what was happening to microglia at the cellular level. In the stressed offspring, Iba1-positive microglia displayed activation-associated morphological changes, shifting toward the amoeboid, hypertrophic appearance characteristic of cells engaged in an inflammatory response. The number of cells double-positive for Iba1 and CD68, a marker of phagocytic activity, increased significantly in both the hippocampus and prefrontal cortex. Most importantly for the study’s central hypothesis, the number of cells co-expressing Iba1 and Galectin-3 also rose markedly, indicating that the upregulated Gal-3 signal was coming specifically from activated microglia rather than from other cell types. Quantitative PCR and Western blotting confirmed the story at the transcript and protein levels: Galectin-3 expression was significantly upregulated in both brain regions, total NF-kappa-B p65 protein, a central transcriptional regulator of inflammation, was increased, and NeuN, a marker of mature neurons, was decreased, all pointing to a process in which microglial inflammation coincides with neuronal loss or dysfunction.

Taken together, the data sketch a coherent mechanistic narrative. Maternal restraint stress during late gestation elevates stress hormones, which appear to program the fetal immune system in a way that persists into adulthood. The programmed microglia become chronically activated, produce Galectin-3, and drive expression of pro-inflammatory cytokines through pathways involving NF-kappa-B signaling. The resulting neuroinflammation in the hippocampus and prefrontal cortex, two regions essential for memory formation and executive function, is accompanied by reduced neuronal marker expression and manifests behaviorally as impaired learning, memory, and anxiety regulation. While the study is correlational in design and does not prove that Galectin-3 causally drives the cognitive deficits, the tight association across behavioral, hormonal, cellular, and molecular layers of evidence makes the protein a strong candidate for future intervention studies.

The clinical implications are significant. If the same biology operates in humans, Galectin-3 could serve as a biomarker for identifying children at risk of stress-related cognitive impairment, potentially allowing earlier intervention. More ambitiously, drugs that inhibit Galectin-3 or dampen microglial activation are already under investigation for other neurological conditions, and the new findings provide a rationale for testing whether such approaches could protect the brains of offspring exposed to prenatal adversity. The researchers caution that their model used restraint stress in rats and that direct extrapolation to human pregnancy requires further work, but the convergence of evidence strengthens a growing consensus in neuroscience: the prenatal environment is not merely a backdrop for development but an active sculptor of the brain’s immune architecture, with consequences that can echo for a lifetime.

The timing of the stress exposure in this model is worth noting. Gestational days 15 through 21 in the rat correspond to a late gestational window during which fetal brain development is particularly sensitive to glucocorticoid exposure, as the hippocampal formation and cortical circuits are actively being organized. Restraining the dams during this period therefore represents a targeted challenge to a developmental phase in which stress hormones can plausibly shape the trajectory of immune and neural maturation.

The choice of markers in the study reflects established conventions in neuroimmunology research. Iba1 is a constitutive marker that labels microglia regardless of their activation state, while CD68 identifies lysosomal and phagocytic activity, so the increase in cells double-positive for both proteins indicates not merely more microglia but microglia shifted toward an active, phagocytic phenotype. Galectin-3 itself is a beta-galactoside-binding lectin that has been linked to Toll-like receptor 4 signaling and NF-kappa-B pathway activation in prior work, which is consistent with the elevated NF-kappa-B p65 protein levels observed here alongside increased Gal-3 expression.

The reduction in NeuN, a marker expressed by mature neurons, is a particularly consequential observation, because it suggests that the inflammatory changes are not simply parallel to neuronal health but may reflect actual neuronal compromise in the hippocampus and prefrontal cortex. However, the study design is cross-sectional and correlational, so it cannot distinguish whether Gal-3 upregulation drives neuronal dysfunction, results from it, or both arise from a shared upstream mechanism such as sustained HPA axis activation. Future experiments using Gal-3 inhibitors or genetic approaches in this prenatal stress paradigm would be needed to establish causality and to determine whether blocking this pathway can rescue the behavioral deficits observed in adult offspring.

Subject of Research: Microglial Galectin-3 expression linked to prenatal stress-induced cognitive dysfunction in adult offspring

Article Title: Microglia-associated Galectin-3 expression in prenatal stress-induced cognitive dysfunction in adult offspring

Article References: Wang, Q., Luo, H., Fan, F., Zhao, Z., Liu, D., Liao, L., & Bai, S. (2026). Microglia-associated Galectin-3 expression in prenatal stress-induced cognitive dysfunction in adult offspring. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01048-9

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01048-9

Keywords: prenatal stress, microglia, Galectin-3, neuroinflammation, cognitive impairment, hippocampus, prefrontal cortex, cytokines, HPA axis, neurodevelopment, BMC Neuroscience, animal model